Mike R.
About Mike R.
Mike R. serves as the Chief Revenue Officer at AliveCor, where he drives growth and profitability for the company's personal cardiology products. He has extensive experience in healthcare operations and has held various leadership roles across multiple organizations, including BD and UpHealth Inc.
Work at AliveCor
Mike R. serves as the Chief Revenue Officer (CRO) at AliveCor, a position he has held since 2023. In this role, he focuses on driving the growth and profitability of AliveCor's personal cardiology suite of products and services. He oversees a global operation that extends across 41 countries and serves over 3 million patients. His leadership aims to enhance the company's market presence and improve patient outcomes through innovative health technology.
Education and Expertise
Mike R. holds a Bachelor of Science (BS) from Penn State University, where he studied from 1995 to 1999. He furthered his education at Emory University - Goizueta Business School, achieving a Master of Business Administration (MBA) with a concentration in Business of Healthcare from 2009 to 2011. He also completed an additional MBA concentration in Business of Healthcare from 2014 to 2015. His educational background equips him with a strong foundation in healthcare management and business operations.
Background
Mike R. has extensive experience in the healthcare and technology sectors. Prior to joining AliveCor, he held various leadership roles, including Chief Growth Officer at CCS and Chief Revenue Officer at UpHealth Inc. His career includes significant positions at BD, where he served in multiple capacities, such as Director of U.S. Clinical Operations and U.S. Director of UCC. His diverse background spans sales, operations, and strategic growth in both public and private sectors.
Achievements
Throughout his career, Mike R. has orchestrated significant growth achievements and operational results. He has broadened his influence as an advisor and board member for select health tech and AI companies since 2018. His philanthropic efforts are dedicated to health equity and healthcare advancement, reflecting his commitment to improving healthcare access and outcomes. His leadership roles have consistently focused on driving growth and enhancing operational efficiency.